Literature DB >> 10881737

Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence.

R P Linke1.   

Abstract

In order to find how best to diagnose amyloid deposits as early as possible, the sensitivity of three different methods that can be applied to the diagnosis of amyloid in tissue sections have been compared: the Congo red staining method (CR), the combination of CR and immunocytochemistry (CRIC) and Congo red fluorescence (CRF). Tissue blocks were available from 25 patients, including 11 with immunohistochemically distinct and 3 with chemically undefined amyloid diseases. The results revealed (a) that CRF is more sensitive than either CR or CRIC, as shown qualitatively and quantitatively, (b) that CRF can therefore be utilized to track down even minute amyloid deposits, which can be missed by the other two methods; (c) that the specificity of CRF and CRIC is secured on double-stained sections by the demonstration of green birefringence (GB) of the CRF-marked and IC-marked areas; (d) that CRF can be performed on the spot by just changing the light source; and (e) that CRF is not hampered by the congruent IC chromogen overlay, which ensures the specific classification of the amyloid deposits as applied to different amyloid classes. In conclusion, CRF was demonstrated to be the most sensitive method for direct diagnosis of amyloid in tissue sections. This method can, therefore, allow the earliest diagnosis and classification of amyloid, which is a good basis for an amyloid class-specific therapy while organ damage is still minimal.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881737     DOI: 10.1007/s004280050471

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  34 in total

1.  [Amyloid diagnostics in rheumatic diseases].

Authors:  C Röcken; J Ernst
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

Review 2.  [Amyloidosis of the heart].

Authors:  A V Kristen; C Röcken
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

Review 3.  [Amyloid and amyloidoses].

Authors:  C Röcken; M Eriksson
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

4.  In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.

Authors:  Jonathan S Wall; Tina Richey; Alan Stuckey; Robert Donnell; Sallie Macy; Emily B Martin; Angela Williams; Keiichi Higuchi; Stephen J Kennel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

5.  Influence of the electric field on supramolecular structure and properties of amyloid-specific reagent Congo red.

Authors:  Paweł Spólnik; Marcin Król; Barbara Stopa; Leszek Konieczny; Barbara Piekarska; Janina Rybarska; Grzegorz Zemanek; Anna Jagusiak; Piotr Piwowar; Grzegorz Szoniec; Irena Roterman
Journal:  Eur Biophys J       Date:  2011-09-24       Impact factor: 1.733

Review 6.  Fibrinogen alpha amyloidosis: insights from proteomics.

Authors:  Jessica Chapman; Ahmet Dogan
Journal:  Expert Rev Proteomics       Date:  2019-08-28       Impact factor: 3.940

Review 7.  Transthyretin Cardiac Amyloidosis in Black Americans.

Authors:  Keyur B Shah; Anit K Mankad; Adam Castano; Olakunle O Akinboboye; Phillip B Duncan; Icilma V Fergus; Mathew S Maurer
Journal:  Circ Heart Fail       Date:  2016-06       Impact factor: 8.790

Review 8.  Transthyretin Cardiac Amyloidosis.

Authors:  Anit K Mankad; Keyur B Shah
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

9.  Heterogeneity in distribution of amyloid-positive islets in type-2 diabetic patients.

Authors:  Cecilia M Borromeo; Xavier Pottier; Peter A In't Veld; Miriam A Pipeleers-Marichal; Leonard Kaufman; Daniel G Pipeleers; Christiaan F Van Schravendijk
Journal:  Virchows Arch       Date:  2005-01-27       Impact factor: 4.064

10.  Altered aggregation properties of mutant gamma-crystallins cause inherited cataract.

Authors:  Aileen Sandilands; Aileen M Hutcheson; Heather A Long; Alan R Prescott; Gijs Vrensen; Jana Löster; Norman Klopp; Raimund B Lutz; Jochen Graw; Shigeo Masaki; Christopher M Dobson; Cait E MacPhee; Roy A Quinlan
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.